Psychological impairment and low-dose benzodiazepine treatment
It is generally accepted that excessive use of benzodiazepines may lead to physical dependence and a withdrawal syndrome, but recently it has been reported that prolonged use of doses within the normally accepted therapeutic range may lead not only to a withdrawal reaction but also to some psychological impairment during treatment.1 2 This conclusion, drawn from studies on coding ability as represented by digit symbol substitution, is, however, hard to accept. The authors observed an improvement in performance during testing, but this occurred before the drug was even partially withdrawn, one group studied remained on full dose for four weeks. Furthermore, both groups experienced similar improvements even though withdrawal was delayed by two weeks in one, and, as judged from the data, the absolute level of performance of this group remained higher throughout the period of testing. These observations, together with the absence of a control group to establish the pattern of learning over a period of 10 weeks, suggest that increased familiarity with the test could not be excluded as the reason for the improvement in performance.
In view of the conclusion reached by Petursson and Lader and of its possible clinical significance we have studied the performance of 10 healthy volunteers on digit symbol substitution.
Subjects, methods, and results
We studied the performance of 10 healthy volunteers (eight men and two women) aged 24-50 years on digit symbol substitution over a period of 10 weeks, and analysed the data with an analysis of variance. The subjects were not familiar with the test, which was carried out as described by Petursson and Lader.2 The mean number of substitutions over the first and second weeks was 44-8 (SEM±3-55). The score increased over the study period, particularly over the first four weeks with sharp increases between weeks 1 and 2 and between weeks 2 and 4 (p < 0 01). During the last six weeks improvement was less pronounced, but even so scores during the eighth and ninth weeks were higher (p < 0-05) than those of any of the first four weeks, and scores during the 10th week were higher than those of any of the first six weeks (see figure) . Substitutions over the last four weeks averaged These changes are similar to those of the two groups of Petursson and Lader,2 which also showed a pronounced increase in substitutions over the first four weeks and a slower but continued improvement thereafter. The mean scores over the first two weeks were 46-0 (SEM±3-7) and 49-9 (SEM±2-9), and, as judged from their data, the mean for each group over the last four weeks was about 15 substitutions above the mean of the first two weeks. Initial scores for the patients diagnosed as having psychiatric problems and for the healthy volunteers were similar, and so there was no evidence that the patients were impaired when they were first introduced to the test.
Comment
Though behavioural effects during withdrawal from low doses of benzodiazepines may be related to the previous use of the drug, the data presented by Petursson and Lader do not suggest that psychological impairment is associated with prolonged use of low doses of benzodiazepines. Indeed, the improvement in performance they observed during withdrawal may be explained by learning alone, and the rate of improvement was at all times similar to that of healthy individuals. An altemative interpretation of the data is that the prolonged use of low doses of benzodiazepines is unlikely to lead to psychological impairment even in those patients who may exhibit some dependency as indicated by a reaction on withdrawal of the drug. 
Case report
The patient, a 19-year-old woman, first presented at the age of 6 with a short history of difficulty with respiration. Laryngeal papillomatosis affecting the entire larynx was diagnosed at endoscopy. The airway problem necessitated a tracheostomy, which has renained to the present day. The disease was partially controlled for the next nine years by repeated endoscopic removal using cup forceps, but her condition gradually deteriorated, with papillomata progressively extending distally to affect the trachea and bronchi.
A series of suction diathermy procedures began when the patient was 15, since when 84 anaesthetics were administered at intervals of one to four weeks.
Method of anaesthesia-To reduce recovery time premedication was with atropine only. Althesin was given intravenously in a dose of 2-4 ml, through an indwelling butterfly needle, followed by 12 mg of Flaxedil (gallamine triethiodide) and 20-50 mg of suxamethonium. A James's tracheostomy tube was inserted. The lungs were inflated with oxygen and the larynx and trachea were sprayed with 5 ml of 4% xylocaine. During suction diathermy of the larynx the lungs were ventilated manually with 50% nitrous oxide and 50% oxygen. Incremental doses of Althesin (1 ml) and suxamethonium (25 mg) were given when necessary. The procedures usually lasted between 10 and 15 minutes.
The total dose of Althesin never exceeded 10 ml and the patient recovered consciousness in three to five minutes. There was no postoperative discomfort and no nausea or vomiting.
Comment
Adverse reactions have been reported with Althesin (alphadolone and alphaxolone in polyoxyethylated castor oil; Glaxo), though the incidence quoted differs considerably.1 2 Commonly reported reactions are those showing features of histamine release ("histaminoid" reactions), bronchospasm, cardiovascular effects, and involuntary muscle movements.
